Hear Henry Roar

  • by: |
  • 03/30/2010
Representative Henry Waxman is at it again.
 
In the wake of health care reform’s passage, several of the country’s top executives have acknowledged the legislation’s negative effect on their companies’ respective operations.
 
In a letter to the CEO’s of AT&T, Caterpillar, Verizon and Deere & Company , Waxman took issue with their position:
 
“The new law is designed to expand coverage and bring down costs, so your assertions are a matter of concern.”

Now Waxman has summoned these CEO’s to appear before the House Energy and Commerce Committee to explain themselves.
 
As Megan McArdle points out, Waxman’s complaint should not be with the executives but rather with the accounting code itself. Indeed it is the obligation of these CEO’s to inform their investors of the impact this law will have on a company’s finances.
 
Meanwhile, Aetna’s CEO Ron Williams has come out to acknowledge what we already know: Premiums will increase.
 
Asked in an interview if premiums would rise, Williams said: The answer is yes, and some of the things that will drive those premiums are significant additional taxes the industry will ultimately have to pay in the first year.”
 
To top it off, the New York Times reported that insurers contested the language of the law that would have forced them to take on children with pre-existing conditions.
 
That prompted Chairman Waxman to respond in this way:
 
“The concept that insurance companies would even seek to deny children coverage exemplifies why we fought for this reform.”
 
The insurers have since backed down.
 
But one can bet that the insurance company CEO’s will be summoned soon as well to appear before Mr. Waxman’s committee.
 
A more cynical person might argue that the purpose of this legislation was to create mass chaos.
 
Can talk of a “public option” be far behind?
 

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog